Caterina Vivaldi

Learn More
Major hepatectomy (MH) is often considered the only possible approach for colorectal liver metastasis (CRLM) at the hepato-caval confluence (CC), but it is associated with high morbidity and mortality. With the aim to reduce MH, we developed the "minor-but-complex" (MbC) technique, which consists in the resection of less than 3 adjacent liver segments with(More)
BACKGROUND The role of second-line chemotherapy (CT) is not established in advanced biliary tract cancer (aBTC). We investigated the outcome of aBTC patients treated with second-line CT and devised a prognostic model. METHODS Baseline clinical and laboratory data of 300 consecutive aBTC patients were collected and association with overall survival (OS)(More)
  • Lorenzo Fornaro, Pinuccia Faviana, Gregorio De, Veronica Vivaldi, Caterina Paolicchi, Elisa Masi +23 others
  • 2016
(2015). Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer. BMC Cancer, 15, article no. 874. For guidance on citations see FAQs. Abstract Background: The enhancer of zeste-homolog 2 (EZH2) is involved in cancer development through gene silencing by trimethylation of lysine 27 of histone 3(More)
Sir, We have read with great interest the recent paper by Portal et al (2015), who reported the results of a prospective multicentre cohort study evaluating the efficacy and safety of nab-paclitaxel plus gemcitabine after FOLFIRINOX failure in patients with metastatic pancreatic cancer (mPC). The authors collected the data of 110 patients from 12 French(More)
The enhancer of zeste-homolog 2 (EZH2) is involved in cancer development through gene silencing by trimethylation of lysine 27 of histone 3 (H3K27me3). The C/C genotype for the EZH2 rs3757441 single-nucleotide polymorphism (SNP) is linked with poor prognosis in metastatic colorectal cancer (CRC), but molecular and pathological characterization of this SNP(More)
  • 1